Defining medical cannabis with Myfanwy Graham
Addiction Audio5 Des 2025

Defining medical cannabis with Myfanwy Graham

In this episode, Dr Elle Wadsworth talks to Dr Myfanwy Graham, a Postgraduate Scholar at Monash University funded by the Australian Government's National Health and Medical Research Council. The interview covers Myfanwy’s data insight paper examining differences in the measurement of medical cannabis use.

  • Why definitions and contexts matter with regards to medical cannabis use [01:05]
  • Four measures of medical cannabis use that Myfanwy explored in the study [02:05]
  • The medical cannabis policy contexts of the US, Australia, and Canada [03:30]
  • The importance of using standardised questions across different countries [05:18]
  • The main findings of the data insight [05:48]
  • Interpretations of medical cannabis use [07:49]
  • The implications of the findings for policy and practice [08:23]
  • Myfanwy’s preferred measure of medical cannabis use [09:30]
  • Self perceptions of being a medical cannabis consumer [10:34]
  • The take-home messages of the study [11:56]


About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health.

About Myfanwy Graham: Myfanwy is a Postgraduate Scholar funded by the Australian Government's National Health and Medical Research Council and a Monash Research Excellence Scholar at the Monash Addiction Research Centre, Monash University. Her research examines the intersection between drug policy and health outcomes with psychoactive medicines (e.g. medical cannabis, psychedelics). She is also a current Fellow at the Schaeffer Center for Health Policy and Economics at the University of Southern California and is a Fulbright Scholar Alumna in public health policy. Myfanwy has completed consultancy work for the Australian Government Department of Health, Disability and Ageing, World Health Organization, the United Nations Office on Drugs and Crime and the National Academies of Sciences, Engineering, and Medicine. She is also a registered pharmacist.

Authors have no conflicts of interest to declare.


Original article: Understanding medical cannabis use internationally: Why definitions and context matter https://doi.org/10.1111/add.70117


The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

Hosted on Acast. See acast.com/privacy for more information.

Episoder(126)

Smoking cessation trials with Zoe Swithenbank

Smoking cessation trials with Zoe Swithenbank

In this episode, Rob Calder talks to Zoe Swithenbank about her recent article looking at how to improve research reports on smoking cessation trials. Zoe talks about the challenges of organising an in...

26 Okt 202325min

Drug Consumption rooms with Laurence Lalanne

Drug Consumption rooms with Laurence Lalanne

In this episode Ben Scher talks to Professor Laurence Lalanne about drug consumption rooms and the recent publication based on the COSINUS cohort study. They cover the range of interventions available...

18 Okt 202320min

Drug consumption rooms with Marie Jauffret-Roustide

Drug consumption rooms with Marie Jauffret-Roustide

In this episode Ben Scher talks to Dr Marie Jauffret-Roustide about drug consumption rooms and the recent publication based on the COSINUS cohort study. They cover a range of issues including the hist...

18 Okt 202337min

Drones delivering Naloxone with Caroline Copeland, Patrick Courtney and Paul Royall

Drones delivering Naloxone with Caroline Copeland, Patrick Courtney and Paul Royall

In this episode, Rob Calder talks to Drs Caroline Copeland, Patrick Courtney and Paul Royall about their recent article assessing the time it would take for drones to deliver naloxone to people who ar...

12 Okt 202328min

Canadian low-risk drinking guidelines

Canadian low-risk drinking guidelines

In this episode Dr Merve Mollaametoglu talks to Dr Catherine Paradis director of health promotion and scientific alcohol lead at the Canadian Centre of Substance Use and Addiction, Dr Kevin Shield fro...

5 Okt 202340min

Social media and alcohol with Brandon Cheng

Social media and alcohol with Brandon Cheng

Dr Elle Wadsworth talks here to Brandon Cheng about his research on social media posting and drinking behaviour. Brandon talks about the influence that media and social media have on young people and ...

26 Sep 202317min

Cannabis, sport and anti-doping regulations with Tom Hudzik

Cannabis, sport and anti-doping regulations with Tom Hudzik

In this episode Dr Rob Calder talks to Dr Thomas Hudzik about his work with the World Anti Doping Agency (WADA). Tom talks about the three principles by which a substance is assessed and how they use ...

21 Sep 202323min

Fentanyl, poly-substance use and the US opioid epidemic with Joseph Friedman

Fentanyl, poly-substance use and the US opioid epidemic with Joseph Friedman

Ben Scher talks to Dr Joseph Friedman about his research on fentanyl overdoses. Joseph explains the four waves of opioid overdoses in the US and how opiate and opioid overdoses have changed.They discu...

13 Sep 202315min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
liberal-halvtime
forskningno
rekommandert
sinnsyn
tomprat-med-gunnar-tjomlid
villmarksliv
rss-overskuddsliv
rss-paradigmepodden
pod-britannia
tidlose-historier
rss-inn-til-kjernen-med-sunniva-rose
fjellsportpodden
nevropodden
nordnorsk-historie
diagnose
kvinnehelsepodden
dekodet-2